Clinical Trial Update: Intravitreal Anti-VEGF in Exudative AMD With Epiretinal Membranes

View source ↗

Summary

A completed clinical trial evaluated intravitreal anti-VEGF therapy for exudative age-related macular degeneration with epiretinal membranes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Epiretinal Membrane

Drugs mentioned

• Intravitreal anti-VEGF therapy (VEGF inhibitor)

Snippet

Sponsor: New England Retina Associates | Conditions: Epiretinal Membrane, Age Related Macular Degeneration | Status: COMPLETED